Authors:
Rosenfeld, R
MacGillivray, M
Carrel, A
Sandberg, D
Allen, D
Fost, N
Lipman, T
Silverman, B
Underwood, L
Brock, D
Citation: R. Rosenfeld et al., The quality-of-life benefits of growth hormone-increased final height: What do we know? - Discussion of papers by Drs. MacGillivray and Sandberg, ENDOCRINOLO, 11(4), 2001, pp. 12S-13S
Authors:
Fost, N
Fleming, L
Brock, D
Kaufman, M
MacGillivray, M
Sandberg, D
Fox, J
Rosenfeld, R
Lipman, T
Pauly, M
Citation: N. Fost et al., Full coverage, partial coverage, no coverage for growth hormone treatment:Madison insurance choices as a microcosm, ENDOCRINOLO, 11(4), 2001, pp. 37S-41S
Authors:
Cook, D
Menzel, P
MacGillivray, M
Sandberg, D
Fost, N
Rosenfeld, R
Pauly, M
Brock, D
Citation: D. Cook et al., Oregon's treatment of human growth hormone therapy: A description and evaluative analysis - Discussion of paper by Dr. Menzel, ENDOCRINOLO, 11(4), 2001, pp. 45S-46S
Authors:
MacGillivray, M
Pauly, M
Menzel, P
Buchanan, A
Brock, D
Allen, D
Diekema, D
Fost, N
Mullahy, J
Citation: M. Macgillivray et al., Access to growth hormone therapy: An economist's perspective - Discussion of Pauly paper, ENDOCRINOLO, 11(4), 2001, pp. 52S-54S
Authors:
Rosenfeld, R
Kappy, M
Diekema, D
Pauly, M
Allen, D
Buchanan, A
Fost, N
Johanson, A
Davenport, M
Silverman, B
Guyda, H
Sandberg, D
Menzel, P
Brock, D
Tesch, L
MacGillivray, M
Citation: R. Rosenfeld et al., Growth hormone treatment until genetic potential is reached - Discussion of Allen and Kappy papers, ENDOCRINOLO, 11(4), 2001, pp. 62S-65S
Authors:
Johanson, A
Buchanan, A
Silverman, B
Fost, N
Brock, D
MacGillivray, M
Brasel, J
Citation: A. Johanson et al., Growth hormone: A paradigm of expansive biotechnologies - Discussion of Buchanan paper, ENDOCRINOLO, 11(4), 2001, pp. 81S-82S
Authors:
Havlik, RJ
Brock, D
Lohman, K
Haskell, W
Snell, P
O'Toole, M
Ribisl, P
Vaitkevicius, P
Spurgeon, HA
Lakatta, EG
Pullen, P
Citation: Rj. Havlik et al., High-density lipoprotein cholesterol and vascular stiffness at baseline inthe activity counseling trial, AM J CARD, 87(1), 2001, pp. 104
Authors:
Teichert-Coddington, D
Manning, B
Eya, J
Brock, D
Citation: D. Teichert-coddington et al., Concentration of 17 alpha-methyltestosterone in hormone-treated feed: Effects of analytical technique, fabrication, and storage temperature, J WORLD A C, 31(1), 2000, pp. 42-50
Citation: G. Izmirlian et al., Estimating incidence of dementia subtypes: assessing the impact of missed cases, STAT MED, 19(11-12), 2000, pp. 1577-1591
Authors:
Havlik, RJ
Izmirlian, G
Petrovitch, H
Ross, GW
Masaki, K
Curb, JD
Saunders, AM
Foley, DJ
Brock, D
Launer, LJ
White, L
Citation: Rj. Havlik et al., APOE-epsilon 4 predicts incident AD in Japanese-American men: The Honolulu-Asia Aging Study, NEUROLOGY, 54(7), 2000, pp. 1526-1529
Authors:
Lynn, J
Teno, J
Dresser, R
Brock, D
Nelson, HL
Nelson, JL
Kielstein, R
Fukuchi, Y
Lu, D
Itakura, H
Citation: J. Lynn et al., Dementia and advance-care planning: Perspectives from three countries on ethics and epidemiology, J CLIN ETH, 10(4), 1999, pp. 271-285